Comparative Studies Reveal Robust HbF Induction By Editing of HBG1/2 Promoters or BCL11A Erythroid-Enhancer in Human CD34+ Cells but That BCL11A Erythroid-Enhancer Editing Is Associated with Selective Reduction in Erythroid Lineage Reconstitution in a Xenotransplantation ModelKai‐Hsin Chang, Haiyan Jiang, Scott Haskett et al.|Blood|2018Cited by 9
Inhibiting TGFβ Signaling in CAR T-Cells May Significantly Enhance Efficacy of Tumor ImmunotherapyQueenie Vong, Blythe Sather, Chris Nye et al.|Blood|2017Cited by 5